Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-09-30
1980-05-13
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31155
Patent
active
042029031
ABSTRACT:
Certain novel acyl cyanoguanidines, their preparation, pharmaceutical compositions and novel methods of treating inflammation and autoimmune diseases such as rheumatoid arthritis are disclosed.
REFERENCES:
patent: 2315765 (1943-04-01), Bindler
patent: 2407161 (1946-09-01), Kaiser et al.
Jones Howard
Shen Tsung-Ying
Merck & Co. , Inc.
Speer Raymond M.
Waddell Frederick E.
Westlake Harry E.
LandOfFree
Acyl cyanoguanidines for treating rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyl cyanoguanidines for treating rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl cyanoguanidines for treating rheumatoid arthritis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-929965